| pubmed-article:19807275 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0556025 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0333117 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0597535 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C2936530 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
| pubmed-article:19807275 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:19807275 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19807275 | pubmed:dateCreated | 2009-10-14 | lld:pubmed |
| pubmed-article:19807275 | pubmed:abstractText | The positive impact of opioid substitution treatment (OST) on opioid-dependent individuals with human immunodeficiency virus (HIV) infection is well documented, especially with regard to adherence to highly active antiretroviral therapy (HAART). We used the data from a 5-year longitudinal study of the MANIF 2000 cohort of individuals infected with HIV (as a result of injection drug use) and receiving HAART to investigate the predictors of long-term virological success. Design. Data were collected every 6 months from outpatient hospital services delivering HIV care in France. We selected all patients who were receiving HAART for at least 6 months (baseline visit) and who had indications for OST (ie, still dependent on opioids). We selected a total of 113 patients, accounting for a total of 562 visits for all the analyses. | lld:pubmed |
| pubmed-article:19807275 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19807275 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19807275 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19807275 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19807275 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19807275 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19807275 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19807275 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19807275 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:Poizot-Martin... | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:RavauxIsabell... | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:DellamonicaPi... | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:SpireBrunoB | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:CarrieriM... | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:RouxPerrineP | lld:pubmed |
| pubmed-article:19807275 | pubmed:author | pubmed-author:CohenJulienJ | lld:pubmed |
| pubmed-article:19807275 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19807275 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19807275 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:19807275 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19807275 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19807275 | pubmed:pagination | 1433-40 | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:meshHeading | pubmed-meshheading:19807275... | lld:pubmed |
| pubmed-article:19807275 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19807275 | pubmed:articleTitle | Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. | lld:pubmed |
| pubmed-article:19807275 | pubmed:affiliation | Institut National de la Santé et de la Recherche Médicale, U912 (SE4S), Marseille, France. perrine.roux@inserm.fr | lld:pubmed |
| pubmed-article:19807275 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19807275 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19807275 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19807275 | lld:pubmed |
